Detalhe da pesquisa
1.
Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer - An NRG/GOG study.
Gynecol Oncol
; 181: 54-59, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38134754
2.
Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials.
Gynecol Oncol
; 183: 103-114, 2024 Apr 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38593674
3.
Smut fungus (Langdonia walkerae) incidence is lower in two bunchgrass species (Aristida stricta and A. beyrichiana) after fires early in the year.
Am J Bot
; 111(2): e16286, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38366863
4.
Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer.
N Engl J Med
; 381(20): 1929-1939, 2019 11 14.
Artigo
Inglês
| MEDLINE | ID: mdl-31722153
5.
A phase II evaluation of temsirolimus with carboplatin and paclitaxel followed by temsirolimus consolidation in clear cell ovarian cancer: An NRG oncology trial.
Gynecol Oncol
; 167(3): 423-428, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36244829
6.
Prognostic significance of ethnicity and age in advanced stage epithelial ovarian cancer: An NRG oncology/gynecologic oncology group study.
Gynecol Oncol
; 164(2): 398-405, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34857397
7.
A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study.
Gynecol Oncol
; 164(3): 481-491, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35063278
8.
Patient-reported outcome changes at the end of life in recurrent platinum-resistant ovarian cancer: An NRG oncology/GOG study.
Gynecol Oncol
; 163(2): 392-397, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34548162
9.
GOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function.
Gynecol Oncol
; 160(1): 244-251, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33109392
10.
Post hoc analyses of GOG 9923: Does BRCA status affect toxicities?: An NRG oncology study.
Gynecol Oncol
; 161(2): 512-515, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33610319
11.
Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers.
Gynecol Oncol
; 160(2): 625-632, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33158510
12.
A phase I study of intravenous or intraperitoneal platinum based chemotherapy in combination with veliparib and bevacizumab in newly diagnosed ovarian, primary peritoneal and fallopian tube cancer.
Gynecol Oncol
; 156(1): 13-22, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31708167
13.
Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG study.
Gynecol Oncol
; 156(1): 131-139, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31759774
14.
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer.
N Engl J Med
; 374(8): 738-48, 2016 Feb 25.
Artigo
Inglês
| MEDLINE | ID: mdl-26933849
15.
GOG 244 - The LymphEdema and Gynecologic cancer (LEG) study: The association between the gynecologic cancer lymphedema questionnaire (GCLQ) and lymphedema of the lower extremity (LLE).
Gynecol Oncol
; 155(3): 452-460, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31679787
16.
Randomized phase II trial of bevacizumab plus everolimus versus bevacizumab alone for recurrent or persistent ovarian, fallopian tube or peritoneal carcinoma: An NRG oncology/gynecologic oncology group study.
Gynecol Oncol
; 151(2): 257-263, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30177462
17.
A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254).
Gynecol Oncol
; 150(2): 247-252, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29921512
18.
Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 150(1): 119-126, 2018 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29778506
19.
Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study.
Am J Obstet Gynecol
; 218(1): 109.e1-109.e11, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29037481
20.
Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study.
Am J Obstet Gynecol
; 219(5): 459.e1-459.e11, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30096321